𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunoglobulin G fragment C receptor polymorphisms and KRAS mutations: Are they useful biomarkers of clinical outcome in advanced colorectal cancer treated with anti-EGFR-based therapy?

✍ Scribed by David Paez; Laia Paré; Iñigo Espinosa; Juliana Salazar; Elisabeth Del Rio; Agustí Barnadas; Eugenio Marcuello; Montserrat Baiget


Book ID
108586780
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
178 KB
Volume
101
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.